Category Archives: Pradaxa
Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits
An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.
1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit
A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...
Federal DePuy ASR Hip Implant Trials Likely to Start This Year
It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds
A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).
Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits
A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...
Actos Bladder Cancer Lawsuit Filed by West Virginia Resident
Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...
Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications
A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...
FDA Gives 7 Companies Go Ahead To Market Generic Plavix
The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...
Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System
Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...
Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings
Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis … Continue reading
Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage
A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening … Continue reading
Pradaxa Bleeding Deaths Reported in 117 More Patients, ISMP Finds
Another 117 bleeding deaths possibly linked to Pradaxa were reported to the U.S. Food & Drug Administration’s (FDA) Adverse Event Database, according to the Institute for Safe Medicine Practices (ISMP) latest QuarterWatch report. The drug watchdog also found that Pradaxa … Continue reading
Pradaxa Patient Died from Severe Brain Bleed Following Minor Trauma
The recent death of a man due to a brain hemorrhage caused by a minor trauma has underscored the dangers of the blood thinner drug Pradaxa. According to a report at MedPageToday.com on a case study conducted by researchers at … Continue reading
Is Pradaxa Worth the Risks?
Pradaxa, a new type of blood thinner approved by U.S. regulators in October 2011, may not be living up to its promise. According to a report from The Cleveland Plain Dealer, at least one study published this year has linked … Continue reading
Cautions Added to Pradax (Pradaxa) Label in Canada for Kidney, Valvular Disease, and Heart Valve Patients
Health Canada today announced that the label for Pradax (dabigatran etexilate) will be updated to include new information regarding its use in kidney patients and those with severe valvular disease or prosthetic heart valves. Pradax is sold under the name … Continue reading
Pradaxa Bleeding Death Detailed in Medical Journal Report
A report released this week is raising more questions about the safety of the blood thinner, Pradaxa. The article, which was published in the Journal of Neurosurgery, describes the death of a Pradaxa patient who died from a cerebral hemorrhage … Continue reading
Pradaxa Bleeding Reports To FDA Pass 500
Pradaxa bleeding reports to the U.S. Food and Drug Administration (FDA) have exceeded 500. Pradaxa, made by Boehringer Ingelheim, was approved by the FDA in October 2010 and is used to prevent strokes in people with atrial fibrillation. The most … Continue reading
Pradaxa Study Sees Increased Heart Attack Risk
A newly-published analysis of Pradaxa clinical trials has found that patients taking the blood thinner have a higher risk for heart attacks and chest pain. Accord to a report in The Wall Street Journal, the findings of the new study … Continue reading
FDA Investigating Pradaxa Bleeding Reports
U.S. health regulators have opened a safety investigation of Pradaxa (dabigatran) following reports of serious bleeding in patients treated with the blood thinner. According to a Drug Safety Communication issued yesterday, the Food & Drug Administration (FDA) is trying to … Continue reading
